Key PointsLong-term growth matters more than a single quarter.
Abbott benefits from multiple healthcare growth trends.Management's outlook could move shares more than earnings.10 stocks we like better than Abbott Laboratories › Abbott Laboratories (NYSE: ABT) reports second-quarter earnings on July 16, and some investors are trying to determine whether to buy the stock before the report is released or wait for the results. But you can't make a p…